Latest Supply Agreements News

MyEco Group Ltd reported an 8.6% rise in FY25 sales driven by strong growth in its global MyEco® product line and new UK retail partnerships, while navigating challenges in resin markets and US tariffs.

South32 warns of an impending impairment expense linked to uncertain electricity supply for its Mozal Aluminium smelter, with FY26 production guidance now under review amid ongoing tariff negotiations.

Australian Agricultural Projects Limited has completed its 2025 olive oil harvest, producing a record 752,600 litres with improved oil quality, despite weather challenges.

Janus Electric has secured a three-year supply deal with Electrovaya to develop advanced lithium-ion battery packs, promising safer, longer-lasting, and lighter batteries for zero-emission heavy vehicles.

Cobram Estate Olives has reported a record 2025 Australian olive harvest with a 10.2% increase in production and forecasts a strong FY2025 EBITDA of $115 million. The company also announces strategic moves including a CEO relocation to the US and acquisition of farming machinery business Leda Ag.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

Metallium Ltd has raised A$50 million to accelerate the commercial launch of its patented Flash Joule Heating technology in the U.S., aiming to revolutionize strategic metal recovery from waste and ore. The company is set to commission its first commercial plant in Texas by early 2026, backed by key partnerships and strong institutional support.

Li-S Energy has secured a collaboration and supply agreement with a leading defence technology firm to test its lithium-sulfur batteries for military applications, marking a strategic step into the global defence sector.

Evion Group’s joint venture in India has secured a significant first shipment of expandable graphite to a leading US company, marking a strategic foothold in the critical minerals supply chain outside China.

Radiopharm Theranostics has inked a clinical supply agreement with Cyclotek to support its Phase 1 trial of RAD 402, a novel radiotherapeutic targeting prostate cancer, set to commence in Australia in late 2025.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a significant supply agreement to enter Germany’s burgeoning medical cannabis market, promising at least A$5.6 million in revenue for FY2026.

FBR Limited has entered a non-binding MOU with Habitat NT for the sale of a Hadrian X robotic block-laying unit, aiming to accelerate construction in Darwin amid a housing shortage and infrastructure upgrades.